C0033223_NCI_NCI-GLOSS | Knowledge4COVID-19

Property	Value
?:definition	The active ingredient in a drug that is used to treat advanced Hodgkin lymphoma and is being studied in the treatment of other types of cancer. Procarbazine blocks cells from making proteins and damages DNA. It may kill cancer cells. It is a type of antineoplastic agent and a type of alkylating agent.
?:hasCUIAnnotation	<https://research.tib.eu/covid-19/entity/C0033223>
?:hasGeneratedBy	<https://research.tib.eu/covid-19/SourceName/NCI_NCI-GLOSS>
?:type	<https://research.tib.eu/covid-19/vocab/AnnotationDefinition>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/C0033223_NCI_NCI-GLOSS>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/C0033223_NCI_NCI-GLOSS>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all